Navigation Links
Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Date:4/22/2008

HONG KONG, April 22 /PRNewswire/ -- OrbusNeich's Genous Bio-engineered R stent will be featured at a sponsored symposium during Angioplasty Summit TCT 2008 Asia Pacific.

The symposium, which will take place on April 23 at the Convention Center of Sheraton Grande Walkerhill Seoul Hotel in Seoul, Korea, includes:
-- "Opening Address" by Seung-Jung Park, the symposium's chairperson, from

12:30 p.m.-12:35 p.m.

-- "Endothelial Progenitor Cell Capture Technology and Beyond" by Michael

Kutryk from 12:35 p.m.-12:50 p.m.

-- "TRIAS HR Pilot Study Long Term Follow-up" by Robbert de Winter of the

Academic Medical Center, Amsterdam, from 12:50 p.m.-1:05 p.m.

-- "HEALING AMI" by Harry Suryapranata from 1:05 p.m.-1:20 p.m.

-- "Q&A Followed by Closing Remarks" by Seung-Jung Park from

1:20 p.m.-1:30 p.m.

"Recent data has highlighted the need for a safer alternative to drug-eluting stents," said Seung-Jung Park. "The data we have seen from both the TRIAS HR Pilot study and the registries underline Genous' superior safety profile with regards to late stage thrombosis."

Unlike drug-eluting stents, Genous, which is coated with an antibody, captures a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process. EPCs circulate in the bloodstream and are involved in the repair of blood vessels. When attracted to the surface of Genous, EPCs rapidly form an endothelial layer over the stent that provides protection against thrombus and minimizes restenosis.

OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous Bio-engineered R stent, an antibody-coated device that is the first-ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. Other products are stents, ballo
'/>"/>

SOURCE OrbusNeich
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. 5W Public Relations Presents the 2008 Body Beautiful Media Symposium Benefiting The Skin Cancer Foundation
2. Symposium to explore role nanoparticles may play in disease
3. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
4. Global Sound Conference Brings Worlds Top Sound Researchers, Technologists and Musicians to Los Angeles for Four Day Symposium
5. Eating Disorders Take Center Stage at iaedp(TM) 2008 Symposium in Orlando, Florida
6. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
7. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
8. Seal Shield Introduces New Silver Seal Washable, Antimicrobial Mouse at HiMSS Healthcare Symposium
9. AAAS symposium to address significant effects of the male parent in reproductive success
10. Symposium on drug-resistant diseases set for annual AAAS conference
11. Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
... in more than a year has highlighted growing compl...mains endemic in the country, experts said Sunday ...he capital Hanoi was killed by the H5N1 strain a w... more people are known to have been infected with ...
...rn after embryo biopsy for preimplantation genetic...mations than those born after artificial reproduct... option for couples at risk of transmitting geneti...a prenatal diagnosis followed by a termination of ...
...wo minutes to cut the umbilical cord after birth, ... reduces the risk of blood disorders . The study ... Hamilton, Canada, and involved more than 1,900 ne...ssistant dean of midwifery at the university, said...
...fied potential chinks in the parasite that causes ...isease that afflicts some 12 million people around...protozoa that cause most cases of leishmaniasis co...ackling this neglected disease are already slender...
Other Medicine News:Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 3Health News:Children Born After PGD as Healthy as Kids Born After ART 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Gene Study Throws Up New Targets for Leishmaniasis 2
(Date:7/6/2008)... BD GeneOhm(TM) Cdiff Assay Submitted for F...Call/ -- BD Diagnostics, a segment,of BD (Becton, ...day the CE,marking of the BD GeneOhm(TM) Cdiff mol...ith Clostridium difficile infection (CDI). It is t...ty, simplicity and speed in one test,procedure. BD...
(Date:7/3/2008)... SAN FRANCISCO, July 3 /- M...hat it will hold a teleconference at 5:00,p.m. EDT...om its,randomized, double-blind, placebo-controlle...ton,s disease., Teleconference/Webcast Details, ... at 5:00 p.m. Eastern,time by telephone, please di...
(Date:7/3/2008)... NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall..."Company") (Amex: SNT ) announced today,that it h...("VGXI") to,supply the plasmid portion of the Comp... 5A gene and siRNA against Factor 5A., Senesco ha... results,using its combination siRNA and plasmid a...
(Date:7/2/2008)... - Top-line Data Expected in Augus... Isolagen(TM), Inc. (Amex:,ILE) announced today th...s,Phase III clinical studies (IT-R-005/006) invest... of nasolabial folds, or wrinkles. The last,person...follow-up visit,and collation of this data has be...
Breaking Medicine Technology:BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 1Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 7Mexicos expanded health insurance improves hypertension treatment 5750 1Mexicos expanded health insurance improves hypertension treatment 5750 2New research to help fight widespread potato disease 1140 1New research to help fight widespread potato disease 1140 2Pollution from marine vessels linked to heart and lung disease 1137 1Pollution from marine vessels linked to heart and lung disease 1137 2
...evention of Cervical Cancer and Other Human,Papill... of Follow,Up in Large Phase III Clinical Studies ...nd Journal of Medicine publishes the most comprehe...lomavirus vaccine , LYON, France, 10th May2007 &nd...nd sustained efficacy of Gardasil® in the,prev...
... Germany, May 10th, 2007 - Antisense,Pharma today ...minary Results of a Phase I/II-Study in Pancreatic...cinoma with the,TGF-beta2 Inhibitor AP 12009&rdquo... 43rd Annual Meeting of the American Society of,Cl...ago, Illinois,U.S.A, from June 1st - 5th. , In th...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: